We are live on ! Find out more
GT

Greenleaf Trust Portfolio holdings

AUM $10.4B
1-Year Est. Return 0.97%
This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$5.25B
AUM Growth
+$215M
Cap. Flow
+$446K
Cap. Flow %
0.01%
Top 10 Hldgs %
86.09%
Holding
615
New
85
Increased
281
Reduced
106
Closed
102

Sector Composition

Rank Sector Weight
1 Healthcare 76.13%
2 Technology 2.43%
3 Financials 2.36%
4 Consumer Discretionary 1.54%
5 Consumer Staples 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
176
Diageo
DEO
$49.6B
$885K 0.02%
6,145
+1,075
+21% +$154K
RPG icon
177
Invesco S&P 500 Pure Growth ETF
RPG
$1.9B
$884K 0.02%
38,515
AZN icon
178
AstraZeneca
AZN
$269B
$882K 0.02%
12,560
+4,335
+53% +$312K
SSL icon
179
Sasol
SSL
$7.4B
$878K 0.02%
24,020
-53
-0.2% -$1.91K
INFY icon
180
Infosys
INFY
$51B
$867K 0.02%
89,268
+47,474
+114% +$425K
IWR icon
181
iShares Russell Mid-Cap ETF
IWR
$55.9B
$856K 0.02%
16,132
+200
+1% +$10.5K
SLB icon
182
SLB Ltd
SLB
$72.7B
$852K 0.02%
12,716
+2,924
+30% +$201K
LAMR icon
183
Lamar Advertising Co
LAMR
$16.7B
$847K 0.02%
12,397
+47
+0.4% +$3.15K
LLY icon
184
Eli Lilly
LLY
$1.08T
$838K 0.02%
9,815
+2,686
+38% +$221K
HBAN icon
185
Huntington Bancshares
HBAN
$34B
$830K 0.02%
56,266
+5,647
+11% +$84.9K
KB icon
186
KB Financial Group
KB
$40.6B
$820K 0.02%
17,648
IDXX icon
187
Idexx Laboratories
IDXX
$44.9B
$813K 0.02%
+3,729
New +$768K
NVS icon
188
Novartis
NVS
$302B
$813K 0.02%
12,012
-2,729
-19% -$188K
AXP icon
189
American Express
AXP
$224B
$807K 0.02%
8,231
+2,109
+34% +$207K
COP icon
190
ConocoPhillips
COP
$144B
$793K 0.02%
11,393
+3,726
+49% +$248K
OMC icon
191
Omnicom Group
OMC
$22.7B
$791K 0.02%
10,369
+403
+4% +$29.8K
RTX icon
192
RTX Corp
RTX
$290B
$789K 0.02%
10,031
+2,529
+34% +$198K
EMR icon
193
Emerson Electric
EMR
$81.6B
$787K 0.02%
11,389
+1,659
+17% +$117K
KMB icon
194
Kimberly-Clark
KMB
$37.6B
$776K 0.01%
7,370
+105
+1% +$10.9K
GSK icon
195
GSK
GSK
$107B
$774K 0.01%
15,352
+4,847
+46% +$244K
PKX icon
196
POSCO
PKX
$14.7B
$764K 0.01%
10,308
ALGN icon
197
Align Technology
ALGN
$12.9B
$751K 0.01%
2,194
+253
+13% +$75.5K
HSY icon
198
Hershey
HSY
$37.3B
$749K 0.01%
8,048
-591
-7% -$55.1K
JXI icon
199
iShares Global Utilities ETF
JXI
$315M
$741K 0.01%
15,138
-18,861
-55% -$920K
VEA icon
200
Vanguard FTSE Developed Markets ETF
VEA
$223B
$739K 0.01%
+17,237
New +$768K

Similar funds

Greenleaf Trust's Q2 2018 Portfolio in Review

As of Q2 2018, Greenleaf Trust held 615 positions worth $5.25B, up 4.3% from $5.04B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Greenleaf Trust's Q2 2018 filing shows 85 new, 281 increased, 106 reduced and 102 closed positions. Its largest new stake was Wendy's: 501,747 shares worth $8.62M. The largest sale was Stryker, an estimated $48.7M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 77% a quarter earlier, followed by Technology and Financials.

  • Greenleaf Trust's largest Q2 2018 buy was Wendy's: 501,747 shares worth $8.62M.
  • Greenleaf Trust added most to iShares Core S&P 500 ETF in Q2 2018, an estimated $20M increase.
  • Greenleaf Trust's biggest Q2 2018 reduction was Stryker, cutting an estimated $48.7M.
  • Greenleaf Trust fully exited Monsanto Co in Q2 2018, selling an estimated $7.14M.
  • Greenleaf Trust's ten largest holdings make up 86% of its $5.25B portfolio in Q2 2018.
  • Greenleaf Trust opened 85 new positions and closed 102 in Q2 2018.
  • Greenleaf Trust's portfolio value rose 4.3% quarter-over-quarter to $5.25B.

Based on Greenleaf Trust's 13F filing for Q2 2018, filed 7 Aug 2018.